Print Page     Close Window     

2019 Newsroom

Keyword Search
 
2019 | 2018 | 2017 | 2016 | 2015
DateTitle
06/13/19R2 Dermatology Announces Signing of Exclusive Asia-Pacific Distribution Agreement with China’s Huadong Medicine Company Limited
SAN RAMON, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- R2 Dermatology (“R2”) announced today that it has entered into an exclusive distribution agreement with China’s Huadong Medicine Company Limited (“Huadong”) for the Asia-Pacific Region. In exchange, Huadong will make an equity investment in R2 Dermatology to fund R2’s next phase of product and market development.  “We are delighted to have found a superb strategic partner in Huadong and particularly excited to work with their entire team ... 
06/13/19Pansend Life Sciences’ Portfolio Company, R2 Dermatology, Enters Into Exclusive China/Asia-Pacific Distribution Agreement
R2 Dermatology Products to be Commercialized and Distributed by Huadong Medicine Company Limited NEW YORK, June 13, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that R2 Dermatology, a privately-held portfolio company within HC2’s Pansend Life Sciences (“Pansend”) subsidiary has entered into a strategic partnership agreement with Huadong Medicine Company Limited (“Huadong”) (SZ: 000963).  In exchange for an equity investment i... 
05/07/19DBM Global Inc., a HC2 Portfolio Company, to Pay Cash Dividend
NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that its operating subsidiary DBM Global Inc. (OTC:DBMG), a family of companies providing fully integrated steel construction services, will pay a cash dividend of $15.0 million, or $3.89 per share, on May 29, 2019 to DBM Global Inc. stockholders of record at the close of business on May 17, 2019.  As the largest stockholder of DBM Global Inc., HC2 expects to receive approx... 
05/07/19HC2 Holdings Reports First Quarter 2019 Results
- First Quarter 2019 Consolidated Net Revenue Grew 8.3% Year-Over-Year to $491.4 Million - - Reaffirms 2019 Guidance for Construction Segment - NEW YORK, May 07, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. ("HC2" or the "Company") (NYSE: HCHC), a diversified holding company, announced today its consolidated results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Consolidated net revenue grew 8.3% year-over-year to $491.4 million. Net loss attributable to common and... 
04/23/19HC2 Holdings to Announce First Quarter 2019 Financial Results
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that it will release its financial results for the first quarter 2019 on Tuesday, May 7, 2019 after the market closes. The Company will host an earnings conference call reviewing these results and its operations the same day, beginning at 5:00 p.m. ET. Participating on the call will be Philip Falcone, Chairman, President and Chief Executive Officer, and Michael J. Sena... 
03/12/19HC2 Holdings Reports Fourth Quarter and Full Year 2018 Results
- Fourth Quarter 2018 Consolidated Total Net Revenue Grew 14.5% Year-Over-Year to  $524.9 million  -   - Full Year 2018 Consolidated Total Net Revenue Grew 21.0% Over 2017 to  $2.0 billion  -    - Full Year 2018 Net Income Attributable to Common and Participating Preferred Stockholders of  $155.6 million  -   - Full Year 2018 Core Operating Subsidiaries Adjusted EBITDA of  $104.4 million  -   - Initiates 2019 Adjusted EBITDA Gu... 
02/28/19HC2 Holdings to Announce Fourth Quarter and Fiscal Year 2018 Financial Results
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (NYSE:HCHC), a diversified holding company, announced today that it will release its financial results for the fourth quarter and fiscal year 2018 on Tuesday, March 12, 2019 after the market closes. The Company will host an earnings conference call reviewing these results and its operations the same day, beginning at 5:00 p.m. ET.  Participating on the call will be Philip Falcone, Chairman, President and Chief Executive Officer,... 
Investor Relation Subsidiary Newsroom
There are currently no news releases.

© Copyright 2015, HC2. All Rights Reserved.